Skip to main content

Lafaille Stephen's Form 4 filing

Tecogen Inc. (TGEN) · filed Jun 24, 2025

Accession no.
0001537435-25-000064
Filed
Jun 24, 2025
Trade date
Mar 3-Jun 23, 2025
Filing delay
113 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions and 4 derivative transactions. Open-market purchases total $1.00K. Open-market sales total $345.8K. It was filed 113 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lafaille StephenCIK 0002074096Officer (VP of Business Development)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2025Common StockPPurchaseAcquired+400$2.50+$1,000400Direct
Jun 3, 2025Common StockXIn-the-money exerciseAcquired+10,000$0.71F1+$7,10010,400Direct
Jun 3, 2025Common StockSSaleDisposed−10,000$4.88F2−$48,800400Direct
Jun 4, 2025Common StockXIn-the-money exerciseAcquired+15,000$0.71F1+$10,65015,400Direct
Jun 4, 2025Common StockSSaleDisposed−15,000$5.00F3−$75,000400Direct
Jun 6, 2025Common StockXIn-the-money exerciseAcquired+25,000$1.10F4+$27,50025,400Direct
Jun 6, 2025Common StockSSaleDisposed−25,000$5.98F5−$149,500400Direct
Jun 23, 2025Common StockXIn-the-money exerciseAcquired+10,000$1.10F4+$11,00010,400Direct
Jun 23, 2025Common StockSSaleDisposed−10,000$7.25−$72,500400Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 3, 2025Common StockXIn-the-money exerciseDisposed−50,000$0.71−$7,10040,000Direct
Jun 4, 2025Common StockXIn-the-money exerciseDisposed−40,000$0.71−$10,65025,000Direct
Jun 6, 2025Common StockXIn-the-money exerciseDisposed−52,500$1.10−$27,50027,500Direct
Jun 23, 2025Common StockXIn-the-money exerciseDisposed−25,000$1.10−$11,00017,500Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Shares acquired pursuant to exercise of Stock Option Agreement dated 7/9/2020

Referenced by the price of 2 transactions in Table I.

F2

Multiple share sales between $4.75 and $5.25 per share

Referenced by the price of 1 transaction in Table I.

F3

10,000 shares sold for $4.90 per share, and 5,000 shares sold for $5.10 per share

Referenced by the price of 1 transaction in Table I.

F4

Shares acquired pursuant to stock option agreement dated 1/21/2022

Referenced by the price of 2 transactions in Table I.

F5

Multiple share sales between $5.85 and $6.10

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)